Scarica l'app Stockscreener
2.67
5.99%
-0.17
Dopo l'orario di chiusura:
2.68
0.01
+0.37%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRBU Giù?
Forum
Previsione
Precedente Chiudi:
$2.84
Aprire:
$2.83
Volume 24 ore:
948.38K
Relative Volume:
0.76
Capitalizzazione di mercato:
$248.64M
Reddito:
$34.48M
Utile/perdita netta:
$-102.07M
Rapporto P/E:
-1.8288
EPS:
-1.46
Flusso di cassa netto:
$-104.90M
1 W Prestazione:
-2.91%
1M Prestazione:
+48.33%
6M Prestazione:
+264.21%
1 anno Prestazione:
+29.61%
Intervallo 1D:
$2.64
$2.94
Intervallo di 1 settimana:
$2.27
$2.94
Portata 52W:
$0.66
$2.9995
Caribou Biosciences Inc Stock (CRBU) Company Profile
Nome
Caribou Biosciences Inc
Settore
Industria
Telefono
510-982-6030
Indirizzo
2929 7TH STREET, SUITE 105, BERKELEY
Confronta CRBU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
2.67 | 227.22M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-11-08 | Iniziato | Cantor Fitzgerald | Neutral |
| 2023-10-31 | Iniziato | Evercore ISI | Outperform |
| 2023-07-11 | Iniziato | Truist | Buy |
| 2022-02-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-12-01 | Iniziato | Oppenheimer | Outperform |
| 2021-11-30 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-15 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-08-17 | Iniziato | BofA Securities | Buy |
| 2021-08-17 | Iniziato | Citigroup | Neutral |
| 2021-08-17 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Caribou Biosciences Inc Borsa (CRBU) Ultime notizie
Published on: 2025-10-16 12:25:29 - newser.com
How high can Caribou Biosciences Inc. stock goSell Signal & Daily Volume Surge Trade Alerts - newser.com
Exit strategy if you’re trapped in Caribou Biosciences Inc.Market Weekly Review & Expert Curated Trade Ideas - newser.com
How Caribou Biosciences Inc. stock compares to market leadersJuly 2025 Drop Watch & Free Community Supported Trade Ideas - newser.com
Technical signs of recovery in Caribou Biosciences Inc.2025 Retail Activity & Stock Market Timing Techniques - newser.com
Intraday pattern recognizer results for Caribou Biosciences Inc.2025 Market Overview & Fast Gain Swing Alerts - newser.com
Pattern recognition hints at Caribou Biosciences Inc. upsidePortfolio Value Summary & Weekly Setup with High ROI Potential - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
What indicators show strength in Caribou Biosciences Inc.Gold Moves & Weekly Top Gainers Alerts - newser.com
How to use Fibonacci retracement on Caribou Biosciences Inc.July 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com
Will Caribou Biosciences Inc. outperform the marketTrade Volume Summary & Weekly Stock Breakout Alerts - newser.com
Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Using AI based signals to follow Caribou Biosciences Inc.Earnings Overview Summary & Weekly High Return Opportunities - newser.com
Evaluating Caribou Biosciences Inc. with trendline analysisTrade Risk Assessment & Daily Technical Forecast Reports - newser.com
Caribou Biosciences, Inc. $CRBU Shares Sold by Public Employees Retirement System of Ohio - Defense World
Real time social sentiment graph for Caribou Biosciences Inc.Market Growth Summary & Daily Risk Controlled Trade Plans - newser.com
Does Caribou Biosciences Inc. fit your quant trading model2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com
How to use a screener to detect Caribou Biosciences Inc. breakoutsRate Hike & Community Verified Trade Signals - newser.com
Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Short interest data insights for Caribou Biosciences Inc.July 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com
Bank of America Securities Sticks to Their Buy Rating for Caribou Biosciences (CRBU) - The Globe and Mail
Combining machine learning predictions for Caribou Biosciences Inc.Trade Signal Summary & Low Risk Entry Point Guides - newser.com
Reversal indicators forming on Caribou Biosciences Inc. stockPortfolio Return Report & Step-by-Step Trade Execution Guides - newser.com
Published on: 2025-10-03 00:57:18 - newser.com
Published on: 2025-10-02 23:00:53 - newser.com
How to monitor Caribou Biosciences Inc. with trend dashboardsJuly 2025 Opening Moves & Pattern Based Trade Signal System - newser.com
CRISPR Therapies Clinical Trial Pipeline Shows Potential - GlobeNewswire
CRISPR Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight - GlobeNewswire Inc.
BofA Securities Maintains Caribou Biosciences(CRBU.US) With Buy Rating - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Caribou Biosciences Inc Azioni (CRBU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Caribou Biosciences Inc Azioni (CRBU) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| MCCLUNG BARBARA G | Chief Legal Officer |
Feb 21 '25 |
Sale |
1.35 |
3,564 |
4,811 |
443,502 |
| Khan Ruhi Ahmad | Chief Business Officer |
Feb 21 '25 |
Sale |
1.35 |
3,564 |
4,811 |
66,936 |
| Kanner Steven | Chief Scientific Officer |
Feb 21 '25 |
Sale |
1.35 |
3,564 |
4,811 |
431,556 |
| Ryali Sriram | Chief Financial Officer |
Jan 29 '25 |
Buy |
1.42 |
17,360 |
24,651 |
17,360 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):